The airway management devices market is experiencing significant expansion, driven by increasing prevalence of chronic respiratory diseases, rising surgical procedures, and breakthrough innovations ...

Teleflex has acquired BIOTRONIK's Vascular Intervention business, enhancing its portfolio and global market presence.

WAYNE, Pa. - Teleflex Incorporated (NYSE:TFX) has completed its acquisition of substantially all of BIOTRONIK SE & Co. KG’s Vascular Intervention business for €760 million, the medical ...

On February 27, 2025, Teleflex announced its entry into a definitive agreement to acquire substantially all of BIOTRONIK’s Vascular Intervention business. Under the terms of the agreement, Teleflex ...

Under the terms of the agreement, Teleflex acquired the Vascular Intervention business for a cash payment of €760 million, less certain adjustments as provided in the purchase agreement ...

On February 27, 2025, Teleflex announced its entry into a definitive agreement to acquire substantially all of BIOTRONIK’s Vascular Intervention business. Under the terms of the agreement ...

WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced ...

July 1, 2025—Teleflex Incorporated announced that it has completed the acquisition of substantially all of the Vascular Intervention business of Biotronik. On February 27, 2025, Teleflex announced it ...

While Teleflex Incorporated (NYSE:TFX) might not have the largest market cap around , it saw significant share price movement during recent months on the NYSE, rising to highs of US$142 and ...

Association of tube thoracostomy and unrecognised endobronchial intubation One hundred forty-two patients underwent tube thoracostomy prior to CT, of whom eight had a TCD <0 cm, including seven with ...